1PHIA Stock Overview
Koninklijke Philips N.V. operates as a health technology company in North America, the Greater China, and internationally.
Snowflake Score | |
---|---|
Valuation | 5/6 |
Future Growth | 4/6 |
Past Performance | 0/6 |
Financial Health | 4/6 |
Dividends | 0/6 |
Rewards
Risk Analysis
No risks detected for 1PHIA from our risk checks.
Koninklijke Philips N.V. Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | €18.40 |
52 Week High | €22.40 |
52 Week Low | €10.16 |
Beta | 0.78 |
1 Month Change | -1.47% |
3 Month Change | -12.37% |
1 Year Change | 25.64% |
3 Year Change | -60.10% |
5 Year Change | -46.44% |
Change since IPO | -29.97% |
Recent News & Updates
Recent updates
Shareholder Returns
1PHIA | IT Medical Equipment | IT Market | |
---|---|---|---|
7D | -3.8% | -5.2% | 1.9% |
1Y | 25.6% | 12.8% | 26.9% |
Return vs Industry: 1PHIA exceeded the Italian Medical Equipment industry which returned 13.3% over the past year.
Return vs Market: 1PHIA matched the Italian Market which returned 26.2% over the past year.
Price Volatility
1PHIA volatility | |
---|---|
1PHIA Average Weekly Movement | 4.0% |
Medical Equipment Industry Average Movement | 3.9% |
Market Average Movement | 4.2% |
10% most volatile stocks in IT Market | 7.9% |
10% least volatile stocks in IT Market | 2.5% |
Stable Share Price: 1PHIA has not had significant price volatility in the past 3 months.
Volatility Over Time: 1PHIA's weekly volatility (4%) has been stable over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
1891 | 69,656 | Roy Jakobs | https://www.philips.com |
Koninklijke Philips N.V. operates as a health technology company in North America, the Greater China, and internationally. The company operates through Diagnosis & Treatment Businesses, Connected Care Businesses, and Personal Health Businesses segments. It also provides diagnostic imaging solutions, includes magnetic resonance imaging, X-ray systems, and computed tomography (CT) systems and software comprising detector-based spectral CT solutions, as well as molecular and hybrid imaging solutions for nuclear medicine; echography solutions focused on diagnosis, treatment planning and guidance for cardiology, general imaging, obstetrics/gynecology, and point-of-care applications; integrated interventional systems, and interventional diagnostic and therapeutic devices to treat coronary artery and peripheral vascular disease.
Koninklijke Philips N.V. Fundamentals Summary
1PHIA fundamental statistics | |
---|---|
Market cap | €16.69b |
Earnings (TTM) | -€456.00m |
Revenue (TTM) | €18.17b |
0.9x
P/S Ratio-36.6x
P/E RatioIs 1PHIA overvalued?
See Fair Value and valuation analysisEarnings & Revenue
1PHIA income statement (TTM) | |
---|---|
Revenue | €18.17b |
Cost of Revenue | €10.72b |
Gross Profit | €7.45b |
Other Expenses | €7.90b |
Earnings | -€456.00m |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
Apr 29, 2024
Earnings per share (EPS) | -0.50 |
Gross Margin | 40.99% |
Net Profit Margin | -2.51% |
Debt/Equity Ratio | 54.8% |
How did 1PHIA perform over the long term?
See historical performance and comparison